Summary Panel Discussion: Evaluating Key Learnings to Best Leverage Preclinical Tools to Optimize Translation of Novel & Traditional ADCS

At the end of the main conference days, rejoin the preclinical presenters for a closing discussion encompassing best deployment of in vivo and in vitro tools, tackling the ADC translational mismatch, and understanding how novel ADC mechanisms and design are being best set up for success in the clinic. Make sure to come with your questions prepared! 

Speakers:

Gail Lewis

Distinguished Scientist, Discovery Oncology

Genentech